Angiotensin II type 1 receptor‑associated protein plays a role in regulating the local renin‑angiotensin system in HSC‑T6 cells

Huang,Haiyang; Zhou,Jie; Cui,Zhonglin; Wang,Biao; Hu,Yunwei

doi:10.3892/mmr.2015.3849

Angiotensin II type 1 receptor‑associated protein plays a role in regulating the local renin‑angiotensin system in HSC‑T6 cells

Authors:
- Haiyang Huang
- Jie Zhou
- Zhonglin Cui
- Biao Wang
- Yunwei Hu
View Affiliations

Affiliations: Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat‑sen University, Guangzhou, Guangdong 510060, P.R. China
Published online on: May 26, 2015 https://doi.org/10.3892/mmr.2015.3849
Pages: 3763-3768

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the current study was to examine the expression of the angiotensin II type 1 receptor‑associated protein (ATRAP) in the rat hepatic stellate cell line HSC‑T6 and to determine its interactions with the local renin‑angiotensin system (RAS). To achieve this goal, the effect of stimulating HSC‑T6 cells with angiotensin II (AngII) and angiotensin‑(1‑7) [Ang‑(1‑7)], on the expression of ATRAP, the angiotensin II type I receptor (AT1R), the Mas receptor and the angiotensin converting enzyme 2 (ACE2) 2, 6, 12, 18, 24 and 36 h after stimulation was investigated. Changes in expression were quantified at the gene and protein level using RT‑qPCR and western blotting, respectively. A single dose of AngII (1 µmol/l) significantly increased the gene expression of ATRAP at 12 h, whereas ACE2 gene expression levels were significantly increased at 6 h and then returned to baseline at 12 h, prior to becoming significantly lower. A single dose of Ang‑(1‑7) at the same concentration as AngII induced ATRAP gene expression, which became statistically significant at the 6 h time‑point, reached a peak at 12 h and remained elevated throughout the experimental time‑course. In addition, ACE2 mRNA expression was significantly suppressed by Ang‑(1‑7) at 6 h, reaching its lowest expression level at 24 h. The expression of AT1R and the Mas receptor were unaffected by stimulation with AngII and Ang‑(1‑7). The western blotting results were generally consistent with the mRNA expression data. In conclusion, it was identified that ATRAP is endogenously expressed in HSC‑T6 cells and therefore, may be critical in regulating the local RAS in these cells.

View Figures

View References

1	Yu L, Nobel NA and Border WA: Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol. 2:177–181. 2002. View Article : Google Scholar : PubMed/NCBI
2	Kim S and Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 52:11–34. 2000.PubMed/NCBI
3	Unger T: The role of the renin angiotensin system in the development of cardiovascular disease. Am J Cardiol. 89:3A–9A. 2002. View Article : Google Scholar
4	Warner FJ, Lubel JS, McCaughan GW and Angus PW: Liver fibrosis: a balance of ACEs? Clin Sci (Lond). 113:109–118. 2007. View Article : Google Scholar
5	Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA and Angus PW: Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol. 35:376–385. 2001. View Article : Google Scholar : PubMed/NCBI
6	Munshi MK, Uddin MN and Glaser SS: The role of the renin-angiotensin system in liver fibrosis. Exp Biol Med (Maywood). 236:557–566. 2011. View Article : Google Scholar
7	Simões e Silva AC, Pinheiro SV, Pereira RM, Ferreira AJ and Santos RA: The therapeutic potential of Angiotensin-(1–7) as a novel Renin-Angiotensin System mediator. Mini Rev Med Chem. 6:603–609. 2006. View Article : Google Scholar
8	Carey RM and Siragy HM: Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev. 24:261–271. 2003. View Article : Google Scholar : PubMed/NCBI
9	Iwai M and Horiuchi M: Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1–7)-Mas receptor axis. Hypertens Res. 32:533–536. 2009. View Article : Google Scholar : PubMed/NCBI
10	Pereira RM, dos Santos RA, da Costa Dias FL, Teixeira MM and Simões e Silva AC: Renin-angiotensin system in the pathogenesis of liver fibrosis. World J Gastroenterol. 15:2579–2586. 2009. View Article : Google Scholar : PubMed/NCBI
11	Guo DF, Sun YL, Hamet P and Inagami T: The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res. 11:165–180. 2001. View Article : Google Scholar : PubMed/NCBI
12	Wang W, Huang Y, Zhou Z, Tang R, Zhao W, Zeng L, Xu M, Cheng C, Gu S, Ying K, Xie Y and Mao Y: Identification and characterization of AGTRAP, a human homolog of murine angiotensin II receptor-associated protein (Agtrap). Int J Biochem Cell Biol. 34:93–102. 2002. View Article : Google Scholar
13	Lopez-Ilasaca M, Liu X, Tamura K and Dzau VJ: The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell. 14:5038–5050. 2003. View Article : Google Scholar : PubMed/NCBI
14	Tamura K, Wakui H, Maeda A, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Haku S, Uneda K, Masuda S, Azuma K, Shigenaga A, Koide Y, Tsurumi-Ikeya Y, Matsuda M, Toya Y, Tokita Y, Yamashita A and Umemura S: The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap. Curr Pharm Des. 19:3043–3048. 2013. View Article : Google Scholar
15	Wakui H, Tamura K, Masuda S, et al: Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension. 61:1203–1210. 2013. View Article : Google Scholar : PubMed/NCBI
16	Wakui H, Tamura K, Matsuda M, Bai Y, Dejima T, Shigenaga A, Masuda S, Azuma K, Maeda A, Hirose T, Ishigami T, Toya Y, Yabana M, Minamisawa S and Umemura S: Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice. Am J Physiol Renal Physiol. 299:F991–F1003. 2010. View Article : Google Scholar : PubMed/NCBI
17	Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL and Blaner WS: An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res. 41:882–893. 2000.PubMed/NCBI
18	Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, Solé M, Colmenero J, Nicolás JM, Jiménez W, Weich N, Gutiérrez-Ramos JC, Arroyo V and Rodés J: Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology. 125:117–125. 2003. View Article : Google Scholar : PubMed/NCBI
19	Daviet L, Lehtonen JY, Tamura K, Griese DP, Horiuchi M and Dzau VJ: Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem. 274:17058–17062. 1999. View Article : Google Scholar : PubMed/NCBI
20	Cui T, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Tamura K, Daviet L and Horiuchi M: ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth. Biochem Biophys Res Commun. 279:938–941. 2000. View Article : Google Scholar
21	Wakui H, Tamura K, Tanaka Y, Matsuda M, Bai Y, Dejima T, Masuda S, Shigenaga A, Maeda A, Mogi M, Ichihara N, Kobayashi Y, Hirawa N, Ishigami T, Toya Y, Yabana M, Horiuchi M, Minamisawa S and Umemura S: Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension. 55:1157–1164. 2010. View Article : Google Scholar : PubMed/NCBI
22	Wakui H, Dejima T, Tamura K, Uneda K, Azuma K, Maeda A, Ohsawa M, Kanaoka T, Azushima K, Kobayashi R, Matsuda M, Yamashita A and Umemura S: Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Cardiovasc Res. 100:511–519. 2013. View Article : Google Scholar : PubMed/NCBI
23	Oppermann M, Gess B, Schweda F and Castrop H: Atrap deficiency increases arterial blood pressure and plasma volume. J Am Soc Nephrol. 21:468–477. 2010. View Article : Google Scholar : PubMed/NCBI
24	Li Z, Wang ZG, Chen X and Chen XD: Inhibitory effect of angiotensin II type 1 receptor-associated protein on vascular smooth muscle cell growth and neointimal formation. Chin Med Sci J. 22:22–26. 2007.PubMed/NCBI
25	Tanaka Y, Tamura K, Koide Y, et al: The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Lett. 579:1579–1586. 2005. View Article : Google Scholar : PubMed/NCBI
26	Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM and Angus PW: Angiotensin-(1–7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond). 117:375–386. 2009. View Article : Google Scholar
27	Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI and Gallagher PE: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 111:2605–2610. 2005. View Article : Google Scholar : PubMed/NCBI
28	Igase M, Strawn WB, Gallagher PE, Geary RL and Ferrario CM: Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1–7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 289:H1013–H1019. 2005. View Article : Google Scholar : PubMed/NCBI
29	Tan Z, Wu J and Ma H: Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1–7) in heart and kidney of spontaneously hypertensive rats. J Renin Angiotensin Aldosterone Syst. 12:413–419. 2011. View Article : Google Scholar : PubMed/NCBI